azetidines - CISMeF

Preferred Label : azetidines;

MeSH annotation : do not confuse with AZETINES;

Is substance : O;

Details

Origin ID

D001384;

UMLS CUI

C0004490;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Azetidine derivative (substance) [SNOMED CT concept]
- azetidine [Substance BNPC]
Ne pas confondre avec
- azetines [MeSH Descriptor]
Record concept(s)
- azetidines [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((-)-7-(3-amino-1-azetidinyl)-8-chloro-1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-3-quinolinecarboxylic acid) [MeSH Supplementary Concept]
- ((-)-7-(3-amino-2-methyl-1-azetidinyl)-8-chloro-1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-3-quinolinecarboxylic acid) [MeSH Supplementary Concept]
- (3,4-dichlorophenyl)(4-((6-azetidinopyridin-2-ylmethylamino)methyl)piperidin-1-yl)methanone [MeSH Supplementary Concept]
- 1,1'-(ethane-1,2-diyl)bis(3-chloro-4-(3,4-dimethoxyphenyl)azetidin-2-one) [MeSH Supplementary Concept]
- 1,3,3-Trinitroazetidine [MeSH Supplementary Concept]
- 1,4-bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone [MeSH Supplementary Concept]
- 1-(2-(2-methyl-4-nitrophenyl)diaz-1-enyl)pyrrolidine-2-carboxylic acid [MeSH Supplementary Concept]
- 1-(2-amino-3-methyl-butyryl)-azetidine-2-carbonitrile [MeSH Supplementary Concept]
- 1-(4-((4-phenyl-5-trifluoromethyl-2-thienyl)methoxy)benzyl)azetidine-3-carboxylic acid [MeSH Supplementary Concept]
- 1-(4-fluorobenzoyl)-3-(((6-methoxy-2-naphthyl)oxy)methyl)azetidine-3-carboxylic acid [MeSH Supplementary Concept]
- 1-(4-methoxyphenyl)-3-acetamido-4-methoxyazetidin-2-one [MeSH Supplementary Concept]
- 1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)(1,3,5)triazin-4-yl)-3-(methylamino)azetidine-3-carboxamide [MeSH Supplementary Concept]
- 1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)-(1,3,5)triazin-4-yl)-3-ethylaminoazetidine-3-carboxylic acid amide [MeSH Supplementary Concept]
- 1-(N-(3-aminopropyl)-N-(3-ammoniopropyl)amino)diazen-1-ium-1,2-diolate-dextran [MeSH Supplementary Concept]
- 1-(N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium-1,2-diolate [MeSH Supplementary Concept]
- 1-O-(4-(1-(4-benzoylphenyl)-3--(3-hydroxy-3-(4-iodophenyl)propyl)-2-oxo-4-azetidinyl)phenyl)glucuronic acid [MeSH Supplementary Concept]
- 1-bromoacetyl-3,3-dinitroazetidine [MeSH Supplementary Concept]
- 1-methyl-2-(3-pyridyl)azetidine [MeSH Supplementary Concept]
- 1-nitro-3,3'-dinitroazetidine [MeSH Supplementary Concept]
- 13-ethyl-4-oxa-13-azabicyclo(10.2.0)tetradec-1-en-14-one [MeSH Supplementary Concept]
- 2,4-dihydroxy-3-fluoroazetidine [MeSH Supplementary Concept]
- 2,4-dimethylazetidine [MeSH Supplementary Concept]
- 2-azetidinone [MeSH Supplementary Concept]
- 2-fluoro-3-(2-azetidinylmethoxy)pyridine [MeSH Supplementary Concept]
- 2-oxo-3-phenyl-1,3-oxazetidine [MeSH Supplementary Concept]
- 2-tetradecylglycidyl-coenzyme A [MeSH Supplementary Concept]
- 2-trifluoromethyl-2-carboxyazetidine [MeSH Supplementary Concept]
- 3,3-dichloro-N-4-methoxyphenyl-4-(2-phenylstyryl)-2-azetidinone [MeSH Supplementary Concept]
- 3,4,5,7-tetrahydroxyconidine [MeSH Supplementary Concept]
- 3-(1'-hydroxyethyl)azetidin-2-one [MeSH Supplementary Concept]
- 3-(1-(1-((4-chlorophenyl)(3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl)methyl)azetidin-3-yl)-2-fluoro-2-methylpropyl)-5-fluorobenzonitrile [MeSH Supplementary Concept]
- 3-(1-tert-butyldimethylsilyloxyethyl)--4-(4-chloro-3-oxo-2-butyl)azetidinone [MeSH Supplementary Concept]
- 3-(1-tert-butyldimethylsilyloxyethyl)-4-(4-bromo-3-oxo-2-butyl)azetidinone [MeSH Supplementary Concept]
- 3-(2-(4-chloro-3-fluorophenyl)-2-(3-fluorophenoxy)ethyl)azetidine [MeSH Supplementary Concept]
- 3-(2-azetidinylmethoxy)-5-(3'-fluoropropyl)pyridine [MeSH Supplementary Concept]
- 3-(2-oxopropylidene)azetidin-2-one [MeSH Supplementary Concept]
- 3-(2-phenethylsulfinyl)-4-(4-hydroxyphenyl)-N-(4-fluorophenyl)-2-azetidinone [MeSH Supplementary Concept]
- 3-(2-phenethylthio)-4-(4-hydroxyphenyl)-N-(4-fluorophenyl)-2-azetidinone [MeSH Supplementary Concept]
- 3-(acetyloxy)-4-phenyl-2-azetidinone [MeSH Supplementary Concept]
- 3-(azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridine [MeSH Supplementary Concept]
- 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride [MeSH Supplementary Concept]
- 3-aminonocardicinic acid [MeSH Supplementary Concept]
- 3-azido-4-oxoazetidine-2-carbaldehyde [MeSH Supplementary Concept]
- 3-benzylazetidin-2-one [MeSH Supplementary Concept]
- 3-chloro-1-((7-chloroquinolin-4-yl)amino)-4-(3,4-dichlorophenyl)azetidin-2-one [MeSH Supplementary Concept]
- 3-chloro-1-((7-chloroquinolin-4-yl)amino)-4-(4-hydroxyphenyl)azetidin-2-one [MeSH Supplementary Concept]
- 3-hydroxy-4-(3-hydroxy-4-methoxyphenyl)-1-(3,4,5-trimethoxyphenyl)azetidin-2-one [MeSH Supplementary Concept]
- 3-mercapto-1-(1,3-thiazolin-2-yl)azetidine [MeSH Supplementary Concept]
- 3-phenyl-1-(1-phenylethyl)-4-(1-phenylethyliminomethyl)azetidin-2-one [MeSH Supplementary Concept]
- 3-phenyl-2-methylazetidine-3-ol [MeSH Supplementary Concept]
- 3-pyridyl-1-methyl-2-(3-pyridyl)azetidine [MeSH Supplementary Concept]
- 4-((4-carboxyphenyl)oxy)-3,3-diethyl-1-(((phenylmethyl)amino)carbonyl)-2-azetidinone [MeSH Supplementary Concept]
- 4-(1-((bis(4-methylphenyl)methyl)carbamoyl)-3-(2-ethoxybenzyl)-4-oxoazetidine-2-yloxy)benzoic acid [MeSH Supplementary Concept]
- 4-(1-(2-(1-(cyclopropylmethyl)-3-(3,4-dichlorophenyl)-6-oxo-3-piperidyl)ethyl)azetidin-3-yl)-1-piperazine sulfamide [MeSH Supplementary Concept]
- 4-(1-(5-(3,4-dimethyl-1H-pyrazol-5-yl)-2,4-dimethylbenzoyl)azetidin-3-yl)benzonitrile [MeSH Supplementary Concept]
- 4-(2-(azetidin-2-yl)ethoxy)-7-chloro-2-oxo-3-(3,4,5-trimethylphenyl)-1,2-dihydroquinoline-6-carboxylic acid pyrimidin-4-ylamide [MeSH Supplementary Concept]
- 4-(3-amido-4-phenyl-2-azetidinonyl)-1-acetophenone [MeSH Supplementary Concept]
- 4-(3-amido-4-phenyl-2-azetidinonyl)-1-phenylacetic acid [MeSH Supplementary Concept]
- 4-(3-amino-2-oxoazetidinonyl-1)methylbenzoic acid [MeSH Supplementary Concept]
- 4-(3-amino-2-oxoazetidinonyl-1)methylcyclohexanecarboxylic acid [MeSH Supplementary Concept]
- 4-(3-fluoroazetidin-1-yl)-7-methyl-5-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)imidazo(5,1-f)(1,2,4)triazine [MeSH Supplementary Concept]
- 4-(3-hydroxy-4-methoxyphenyl)-3-(4-hydroxyphenyl)-1-(3,4,5-trimethoxyphenyl)azetidin-2-one [MeSH Supplementary Concept]
- 4-acetoxy-2-azetidinone [MeSH Supplementary Concept]
- 4-acetoxy-3-hydroxyethyl-2-azetidinone [MeSH Supplementary Concept]
- 4-benzyloxycarbonyl-1-(3'-(benzyloxycarbonyl)phenylacetate)-3(4'-hydroxybenzyl)-2-azetidinone [MeSH Supplementary Concept]
- 4-cyano-N-(2-(3-hydroxyazetidin-1-yl)-1-phenylethyl)-N-methylbenzamide [MeSH Supplementary Concept]
- 5-((76)Br)bromo-3-((2-azetidinyl)methoxy)pyridine [MeSH Supplementary Concept]
- 5-(11C)methyl-3-(2-(S)-azetidinylmethoxy)pyridine [MeSH Supplementary Concept]
- 5-(2-azetidinylmethoxy)-2-chloropyridine [MeSH Supplementary Concept]
- 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide [MeSH Supplementary Concept]
- 5-(5-acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethyl-3-azetidinyl)-2,6-dihydro-7H-pyrazolo(4,3-d)pyrimidin-7-one [MeSH Supplementary Concept]
- 5-iodo-3-(2-azetidinylmethoxy)pyridine [MeSH Supplementary Concept]
- 6-chloro-3-((2-azetidinyl)methoxy)-5-(2-fluoropyridin-5-yl)pyridine [MeSH Supplementary Concept]
- 6-fluoro-3-(2-azetidinylmethoxy)pyridine [MeSH Supplementary Concept]
- 7-(3-aminoazetidin-1-yl)-1-(5-amino-2,4-difluorophenyl)-8-chloro-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid [MeSH Supplementary Concept]
- A 85380 [MeSH Supplementary Concept]
- AHR 11748 [MeSH Supplementary Concept]
- AR-H067637 [MeSH Supplementary Concept]
- ARS853 [MeSH Supplementary Concept]
- AZ12504948 [MeSH Supplementary Concept]
- AZ3976 [MeSH Supplementary Concept]
- AZD 0837 [MeSH Supplementary Concept]
- AZD 2738 [MeSH Supplementary Concept]
- AZD 8081 [MeSH Supplementary Concept]
- AZD1656 [MeSH Supplementary Concept]
- AZD1979 [MeSH Supplementary Concept]
- AZD2927 [MeSH Supplementary Concept]
- AZD5122 [MeSH Supplementary Concept]
- AZD9833 [MeSH Supplementary Concept]
- BDF 9148 [MeSH Supplementary Concept]
- BMS-262084 [MeSH Supplementary Concept]
- BMS-816336 [MeSH Supplementary Concept]
- BRD4592 [MeSH Supplementary Concept]
- CA 432 [MeSH Supplementary Concept]
- CE-178253 [MeSH Supplementary Concept]
- CNX-2006 [MeSH Supplementary Concept]
- DMP 777 [MeSH Supplementary Concept]
- E 4695 [MeSH Supplementary Concept]
- GDC-0276 [MeSH Supplementary Concept]
- GSK2586184 [MeSH Supplementary Concept]
- INCB039110 [MeSH Supplementary Concept]
- JNJ-41443532 [MeSH Supplementary Concept]
- JNJ-42119779 [MeSH Supplementary Concept]
- JTE-952 [MeSH Supplementary Concept]
- L 652117 [MeSH Supplementary Concept]
- L 684248 [MeSH Supplementary Concept]
- LY368052 [MeSH Supplementary Concept]
- N-(2-chloromethylphenyl)-3,3-difluoroazetidin-2-one [MeSH Supplementary Concept]
- N-hydroxymelagatran [MeSH Supplementary Concept]
- N-thiopivaloylazetidin-3-ol [MeSH Supplementary Concept]
- N-tosyloxy-3-phthalimido-4-methyl-2-azetidinone [MeSH Supplementary Concept]
- N-tosyloxy-4-phenyl-2-azetidinone [MeSH Supplementary Concept]
- PF 03376056 [MeSH Supplementary Concept]
- PF-04279405 [MeSH Supplementary Concept]
- PF-5190457 [MeSH Supplementary Concept]
- RRx-001 [MeSH Supplementary Concept]
- RSR056 azetidine [MeSH Supplementary Concept]
- S-2-aminomethylazetidine [MeSH Supplementary Concept]
- SB 222657 [MeSH Supplementary Concept]
- SB-216477 [MeSH Supplementary Concept]
- SCH 58053 [MeSH Supplementary Concept]
- SCH 60663 [MeSH Supplementary Concept]
- SF 2185 [MeSH Supplementary Concept]
- SMC-3176 [MeSH Supplementary Concept]
- SPI-1865 [MeSH Supplementary Concept]
- SRX246 [MeSH Supplementary Concept]
- TVB-3664 [MeSH Supplementary Concept]
- VER 156084 [MeSH Supplementary Concept]
- VU0455691 [MeSH Supplementary Concept]
- WQ-3810 [MeSH Supplementary Concept]
- YL-2-203 [MeSH Supplementary Concept]
- ZGN-1061 [MeSH Supplementary Concept]
- azetidin-2-one [MeSH Supplementary Concept]
- azetidine [MeSH Supplementary Concept]
- azetidine platinum(II) [MeSH Supplementary Concept]
- azetidyl-2-carboxylic acid [MeSH Supplementary Concept]
- azetirelin [MeSH Supplementary Concept]
- baricitinib [MeSH Supplementary Concept]
- ceralifimod [MeSH Supplementary Concept]
- cilofexor [MeSH Supplementary Concept]
- cobimetinib [MeSH Supplementary Concept]
- dirhodium(II) tetrakis(methyl 2-oxaazetidine-4-carboxylate) [MeSH Supplementary Concept]
- ethyl melagatran [MeSH Supplementary Concept]
- ezetimibe glucuronide [MeSH Supplementary Concept]
- fluzinamide [MeSH Supplementary Concept]
- liptruzet [MeSH Supplementary Concept]
- melagatran [MeSH Supplementary Concept]
- nezulcitinib [MeSH Supplementary Concept]
- okaramine B [MeSH Supplementary Concept]
- penaresidin B [MeSH Supplementary Concept]
- sarolaner [MeSH Supplementary Concept]
- sazetidine-A [MeSH Supplementary Concept]
- seliforant [MeSH Supplementary Concept]
- siponimod [MeSH Supplementary Concept]
- tabtoxinine beta-lactam [MeSH Supplementary Concept]
- tazadolene succinate [MeSH Supplementary Concept]
- ximelagatran [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients